BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11287419)

  • 1. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain.
    Grzeszkiewicz TM; Kirschling DJ; Chen N; Lau LF
    J Biol Chem; 2001 Jun; 276(24):21943-50. PubMed ID: 11287419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans.
    Chen N; Chen CC; Lau LF
    J Biol Chem; 2000 Aug; 275(32):24953-61. PubMed ID: 10821835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts.
    Chen CC; Chen N; Lau LF
    J Biol Chem; 2001 Mar; 276(13):10443-52. PubMed ID: 11120741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts.
    Chen CC; Mo FE; Lau LF
    J Biol Chem; 2001 Dec; 276(50):47329-37. PubMed ID: 11584015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans.
    Grzeszkiewicz TM; Lindner V; Chen N; Lam SC; Lau LF
    Endocrinology; 2002 Apr; 143(4):1441-50. PubMed ID: 11897702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.
    Leu SJ; Lam SC; Lau LF
    J Biol Chem; 2002 Nov; 277(48):46248-55. PubMed ID: 12364323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions.
    Schober JM; Chen N; Grzeszkiewicz TM; Jovanovic I; Emeson EE; Ugarova TP; Ye RD; Lau LF; Lam SC
    Blood; 2002 Jun; 99(12):4457-65. PubMed ID: 12036876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
    Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
    J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion.
    Kireeva ML; MO FE; Yang GP; Lau LF
    Mol Cell Biol; 1996 Apr; 16(4):1326-34. PubMed ID: 8657105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61).
    Leu SJ; Liu Y; Chen N; Chen CC; Lam SC; Lau LF
    J Biol Chem; 2003 Sep; 278(36):33801-8. PubMed ID: 12826661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo.
    Babic AM; Chen CC; Lau LF
    Mol Cell Biol; 1999 Apr; 19(4):2958-66. PubMed ID: 10082563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3.
    Kireeva ML; Lam SC; Lau LF
    J Biol Chem; 1998 Jan; 273(5):3090-6. PubMed ID: 9446626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
    Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
    Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo.
    Camenisch G; Pisabarro MT; Sherman D; Kowalski J; Nagel M; Hass P; Xie MH; Gurney A; Bodary S; Liang XH; Clark K; Beresini M; Ferrara N; Gerber HP
    J Biol Chem; 2002 May; 277(19):17281-90. PubMed ID: 11877390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3).
    Jedsadayanmata A; Chen CC; Kireeva ML; Lau LF; Lam SC
    J Biol Chem; 1999 Aug; 274(34):24321-7. PubMed ID: 10446209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells.
    Chen N; Leu SJ; Todorovic V; Lam SC; Lau LF
    J Biol Chem; 2004 Oct; 279(42):44166-76. PubMed ID: 15308622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter function of the angiogenic inducer Cyr61gene in transgenic mice: tissue specificity, inducibility during wound healing, and role of the serum response element.
    Latinkic BV; Mo FE; Greenspan JA; Copeland NG; Gilbert DJ; Jenkins NA; Ross SR; Lau LF
    Endocrinology; 2001 Jun; 142(6):2549-57. PubMed ID: 11356704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
    Brigstock DR
    Angiogenesis; 2002; 5(3):153-65. PubMed ID: 12831056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.
    Babic AM; Kireeva ML; Kolesnikova TV; Lau LF
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6355-60. PubMed ID: 9600969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.
    Menéndez JA; Mehmi I; Griggs DW; Lupu R
    Endocr Relat Cancer; 2003 Jun; 10(2):141-52. PubMed ID: 12790776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.